Session

24.09.2021     08:00–09:30

Titel:
Best Abstracts
Art:
Vortragssitzung
Raum:
Raum 2

24.09.2021
08:00–09:30

Titel:
Best Abstracts
Art:
Vortragssitzung
Raum:
Raum 2

08:00–08:10
VS-17-1 Digital transformation for secure blood donations and donor service
Norbert Niklas (Linz/AT), Claudia Loimayr (Linz/AT)
Redezeit: 6 + 4 min

08:10–08:20
VS-17-2 CARAMBA: GMP-Manufacturing of SLAMF7-CAR-T cells to treat multiple myeloma
Annekarin Meyer (Frankfurt am Main/DE)
Redezeit: 6 + 4 min

08:20–08:30
VS-17-3 Iloprost prevents antibody induced thrombus formation in COVID-19
Jan Zlamal (Tübingen/DE)
Redezeit: 6 + 4 min

08:30–08:40
VS-17-4 Inhibition of apoptosis in cold-stored platelet concentrates improves cell viability without impairing platelets' functionality
Irene Marini (Tübingen/DE)
Redezeit: 6 + 4 min

08:40–08:50
VS-17-5 Genetic engineering of the kidney to silence MHC expression during ex vivo perfusion
Yuliia Yuzefovych (Hannover/DE), Constanca Figueiredo (Hannover/DE)
Redezeit: 6 + 4 min

08:50–09:00
VS-17-6 Effect of high titer convalescent plasma in hospitalized patients with COVID-19: results from the randomized open label clinical trial CAPSID
Sixten Körper (Ulm/DE)
Redezeit: 6 + 4 min

09:00–09:10
VS-17-7 Fully-phased reference sequences for ABO blood group gene alleles by long-read Nanopore sequencing: putative ABO*A1-specific single-nucleotide variants revealed
Maja P. Mattle-Greminger (Schlieren/CH)
Redezeit: 6 + 4 min

09:10–09:20
VS-17-9 Pre-analytic depletion of medicinal anti-CD38 antibody from patient plasma for immunohematology testing
Elisabeth Ehrend (Frankfurt am Main/DE)
Redezeit: 6 + 4 min

09:20–09:30
VS-17-10 Large deletion of the complete PIGA gene and flanking regions in a patient with PNH
Myriam Lorenz (Ulm/DE)
Redezeit: 6 + 4 min